Yes, asthma is a chronic lung disease. It is formally classified as an obstructive lung disease, meaning it makes it harder to push air out of the lungs. Nearly 25 million people in the United States live with asthma, including about 4.7 million children.
How Asthma Qualifies as a Lung Disease
Asthma meets all the criteria for a lung disease because the problem originates in the airways inside the lungs. The CHEST Journal, a major pulmonary medicine publication, defines asthma as “a lung disease” with three defining characteristics: airway obstruction that is reversible (either on its own or with treatment), chronic airway inflammation, and heightened sensitivity of the airways to various triggers.
What makes asthma specifically an obstructive lung disease is the way it interferes with breathing. In obstructive diseases, the airways narrow, making it difficult to fully exhale. After breathing out as hard as you can, an abnormally large amount of air stays trapped in your lungs. This is different from restrictive lung diseases, where the lungs themselves become stiff or the chest wall can’t expand properly, making it hard to inhale. Asthma affects the exhale side of the equation.
Other well-known obstructive lung diseases include COPD and emphysema. Asthma shares the same broad category but behaves differently in important ways.
What Happens Inside the Lungs
Asthma involves a chain reaction in the airways. The immune system drives chronic inflammation, primarily through a type of immune response that produces specific signaling molecules. These signals cause several things to happen at once: the muscles wrapping around the airways tighten and squeeze them narrower, the lining of the airways swells, and the cells lining the airways produce excess mucus. All three of these changes shrink the space available for air to move through.
This process also makes the airways hyperresponsive, meaning they overreact to things that wouldn’t bother someone without asthma. Pollen, cold air, exercise, smoke, or even strong emotions can set off a flare. The immune system essentially treats these triggers as threats and launches a disproportionate response, narrowing the airways rapidly and producing the wheezing, chest tightness, and shortness of breath that define an asthma attack.
Asthma Can Change the Lungs Over Time
One of the most important things to understand about asthma is that it isn’t just about temporary flare-ups. In people with long-lasting or poorly controlled asthma, the airways can undergo permanent structural changes, a process called airway remodeling. The smooth muscle around the airways thickens and grows. A layer of collagen builds up beneath the airway lining, making it stiffer. The cells that produce mucus multiply, leading to chronic overproduction. New blood vessels even form in the airway walls.
When remodeling happens, airflow obstruction can become persistent and no longer fully reversible with medication. This is why early and consistent treatment matters. Not everyone with asthma develops remodeling, but the risk increases the longer inflammation goes uncontrolled.
How Asthma Differs From COPD
Because asthma and COPD are both obstructive lung diseases, people sometimes confuse them. The key difference is reversibility. In asthma, the airway narrowing typically reverses with a bronchodilator (a medication that relaxes the airway muscles). Doctors confirm this with a breathing test called spirometry: if lung function improves by more than 12% after inhaling a bronchodilator, the pattern is consistent with asthma. In COPD, the obstruction does not reverse.
The two diseases also tend to start at different points in life. Asthma risk factors include preterm birth, childhood respiratory symptoms, a family history of asthma or allergies, eczema, and obesity. COPD, by contrast, is most commonly linked to tobacco use and long-term exposure to air pollution, and it typically appears later in life. Some people do develop features of both conditions, which complicates treatment, but the underlying mechanisms are distinct.
How Asthma Is Diagnosed
Spirometry is the primary tool for confirming asthma. You blow as hard and fast as you can into a device that measures how much air you can exhale in one second and the total volume you can push out. If the ratio between these two numbers falls below expected values, that signals obstruction. The next step is to repeat the test after using an inhaled bronchodilator. If your lung function improves by more than 10% of the predicted value, that response supports an asthma diagnosis.
Severity is then graded based on how much obstruction remains. For adults 12 and older, intermittent and mild persistent asthma show normal or near-normal ratios between flares, while moderate persistent asthma shows a measurable drop and severe persistent asthma shows a larger reduction. For children aged 5 to 11, the thresholds are different: moderate persistent asthma corresponds to a ratio of 75 to 80%, and severe persistent falls below 75%. It’s worth noting that normal spirometry results between episodes don’t rule asthma out, since the airways may only narrow in response to specific triggers.
How It’s Managed
Current international guidelines center asthma treatment on inhaled corticosteroids, which reduce the underlying inflammation, combined with a long-acting bronchodilator called formoterol. For people with mild asthma, using this combination inhaler only when symptoms appear (rather than every day) reduces the risk of emergency department visits and hospitalizations by 37% compared to older approaches that relied on a daily preventive inhaler plus a separate rescue inhaler.
For moderate to severe asthma, the same combination is used both as a daily maintenance treatment and as a rescue inhaler during flares. This single-inhaler approach simplifies the regimen significantly. You adjust how often you use it based on how you’re feeling, without needing to switch between different medications. As severity increases, doctors may increase the dose or add other treatments, but the foundation stays the same: control the inflammation consistently to prevent the airway damage that makes asthma worse over time.
About 8% of U.S. adults and 6.5% of children currently have asthma. For most, consistent treatment keeps symptoms manageable and protects lung function long-term. The fact that asthma is a chronic lung disease doesn’t mean it has to be a disabling one, but it does mean it requires ongoing attention rather than treatment only during flare-ups.